120 related articles for article (PubMed ID: 9261631)
1. Unresectable pancreatic cancer: is a multi-modality approach a promising therapeutical alternative?
Lygidakis NJ; Dedemati G; Spenzaris N; Theodoropoulou M
Hepatogastroenterology; 1997; 44(16):1222-8. PubMed ID: 9261631
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic head carcinoma: is pancreatic resection indicated for patients with stage III pancreatic duct cancer?
Lygidakis NJ; Papadopoulou P
Hepatogastroenterology; 1995; 42(5):587-96. PubMed ID: 8751219
[TBL] [Abstract][Full Text] [Related]
3. Hypoxic abdominal stop-flow perfusion in the treatment of advanced pancreatic cancer: a phase II evaluation/trial.
Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Caterino GP; Di Giuro G; Amicucci G
Eur J Surg Oncol; 2007 Feb; 33(1):72-8. PubMed ID: 17166688
[TBL] [Abstract][Full Text] [Related]
4. Combined immunopharmaceutical therapy of patients with unresectable pancreatic carcinoma.
Lygidakis NJ; Ziras FA; Kyparidou E; Parissis J; Papadopoulou P; Venetsanou B
Hepatogastroenterology; 1995; 42(6):1039-52. PubMed ID: 8847017
[TBL] [Abstract][Full Text] [Related]
5. [Regional chemotherapy in advanced pancreatic carcinoma].
Gansauge F; Link KH; Rilinger N; Kunz R; Beger HG
Med Klin (Munich); 1995 Sep; 90(9):501-5. PubMed ID: 7476726
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant therapy following pancreatic resection for pancreatic duct carcinoma: a prospective randomized study.
Lygidakis NJ; Stringaris K
Hepatogastroenterology; 1996; 43(9):671-80. PubMed ID: 8799414
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.
Nakamura M; Wada J; Suzuki H; Tanaka M; Katano M; Morisaki T
Anticancer Res; 2009 Mar; 29(3):831-6. PubMed ID: 19414316
[TBL] [Abstract][Full Text] [Related]
8. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
9. Consecutive re-explorations for final resection of initially unresectable pancreatic head carcinoma.
Lygidakis NJ; Vlachos L; Raptis S; Sgourakis G; Mourikis D; Kehagias D
Hepatogastroenterology; 1999; 46(28):2229-39. PubMed ID: 10521972
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant regional chemotherapy in advanced pancreatic cancer: results of a prospective study.
Beger HG; Link KH; Gansauge F
Hepatogastroenterology; 1998; 45(21):638-43. PubMed ID: 9684109
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of cell mediated immunity in advanced pancreatic carcinoma before and after treatment with interleukin-2 (IL-2).
Abdel-Wahab M; El-Shennawy F; Agha S; Ragab E; Fathi O; Sultan A; Elghawalby N; Ezzat F
Hepatogastroenterology; 1999 May; 46 Suppl 1():1293-6. PubMed ID: 10429977
[TBL] [Abstract][Full Text] [Related]
12. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
[TBL] [Abstract][Full Text] [Related]
14. Intraoperative radiotherapy in the combined-modality management of pancreatic cancer.
Schuricht AL; Spitz F; Barbot D; Rosato F
Am Surg; 1998 Nov; 64(11):1043-9. PubMed ID: 9798766
[TBL] [Abstract][Full Text] [Related]
15. The role of circulating dendritic cells in patients with unresectable pancreatic cancer.
Hirooka S; Yanagimoto H; Satoi S; Yamamoto T; Toyokawa H; Yamaki S; Yui R; Inoue K; Michiura T; Kwon AH
Anticancer Res; 2011 Nov; 31(11):3827-34. PubMed ID: 22110205
[TBL] [Abstract][Full Text] [Related]
16. [Arterial infusion chemotherapy combined with concurrent radiotherapy for local advanced pancreatic cancer].
Liu X; Chen J; Yao W
Zhonghua Zhong Liu Za Zhi; 1999 Sep; 21(5):369-70. PubMed ID: 11776577
[TBL] [Abstract][Full Text] [Related]
17. Management of advanced pancreatic cancer: staging laparoscopy and immunochemotherapy--a new treatment strategy.
Kishiwada M; Kawarada Y; Taoka H; Isaji S
Hepatogastroenterology; 2002; 49(48):1704-6. PubMed ID: 12397771
[TBL] [Abstract][Full Text] [Related]
18. Results of immunochemo-surgery for gastric carcinoma.
Kim JP; Yu HJ; Lee JH
Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936
[TBL] [Abstract][Full Text] [Related]
19. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
Ridwelski K; Meyer F; Schmidt U; Lippert H
Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
[TBL] [Abstract][Full Text] [Related]
20. Intra-arterial infusion chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer: a feasibility study.
Sasada T; Denno R; Tanaka T; Kanai M; Mizukami Y; Kohno S; Takabayashi A
Am J Clin Oncol; 2008 Feb; 31(1):71-8. PubMed ID: 18376231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
